Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Washington Court Hotel

25 sep 2013 8:00 a.m. - 27 sep 2013 5:00 p.m.

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

Nigel R. Richardson, PHD

Nigel R. Richardson, PHD

Head Analytical Technology & Automation, CMC Analytical

GlaxoSmithKline, United Kingdom

Speaker(s)

Mike L. Webb

Advances in Analytical Approaches to Impurity Control for Commercial Oligonucleotides

Mike L. Webb

GlaxoSmithKline, United Kingdom

Vice President, API Chemistry & Analysis

Mike L. Webb

Panelist

Mike L. Webb

GlaxoSmithKline, United Kingdom

Vice President, API Chemistry & Analysis

Rao  Kambhampati, PHD

Rao Kambhampati, PHD

FDA, United States

Senior Chemist, CDER

René  Thürmer, PHD

René Thürmer, PHD

Federal Institute for Drugs and Medical Devices, Germany

Quality Assessor

Christoph  Rosenbohm, PHD, MBA

Christoph Rosenbohm, PHD, MBA

Roche Innovation Center Copenhagen, Denmark

Vice President, Head of Discovery Operations

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.